Tag: Diabetes: Types
FDA Approves First Biosimilar Insulin Product
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Diabetes of Exocrine Pancreas Often Classified as T2DM
Worse glycemic control, more insulin use for diabetes following pancreatic disease than type 2 diabetes
